The tumor immune environment in advanced breast cancer following treatment with pembrolizumab and nab-paclitaxel

被引：0
|
作者：
Tyagi, Apoorvi
Voloshyna, Iryna
Klar, Natalie
Darvishian, Farbod
Hao, Yuan
Zhurova, Anastasia
Cynthia, Loomis
Marks, Douglas K.
Adams, Sylvia
Krogsgaard, Michelle
机构：
来源：
JOURNAL OF IMMUNOLOGY | 2024年 / 212卷 / 01期
关键词：
D O I：
10.4049/jimmunol.212.supp.0730.7079
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer
    Borazanci, Erkut
    Von Hoff, Daniel D.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 739 - 747
  • [42] Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer
    Mahipal, Amit
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Goyal, Gaurav
    Soares, Heloisa
    Neuger, Anthony
    Copolla, Domenico
    Kim, Jongphil
    Kim, Richard
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (03) : 473 - 481
  • [43] Pilot study of carboplatin, nab-paclitaxel and pembrolizumab for metastatic triple-negative breast cancer (ongoing clinical trial)
    Baar, J.
    Abraham, J.
    Silverman, P.
    Budd, G. T.
    Vinayak, S.
    Varadan, V.
    Moore, H.
    Montero, A.
    Fu, P.
    CANCER RESEARCH, 2017, 77
  • [44] Phase II trial of pembrolizumab in combination with nab-paclitaxel in patients with metastatic HER2-negative breast cancer
    Kwa, Maryann J.
    Iwano, Alyssa
    Esteva, Francisco J.
    Novik, Yelena
    Speyer, James L.
    Oratz, Ruth
    Meyers, Marleen Iva
    Axelrod, Deborah M.
    Hogan, Rebecca
    Mendoza, Sandra
    Goldberg, Judith D.
    Muggia, Franco
    Adams, Sylvia
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer
    Amit Mahipal
    Sri Harsha Tella
    Anuhya Kommalapati
    Gaurav Goyal
    Heloisa Soares
    Anthony Neuger
    Domenico Copolla
    Jongphil Kim
    Richard Kim
    Investigational New Drugs, 2019, 37 : 473 - 481
  • [46] NAB-PACLITAXEL ( NAB-P): nanoparticle albumin-bound paclitaxel: efficacy and toxicity evaluation: our experience in advanced pancreatic and breast cancer
    Burattini, E.
    Satta, F.
    Pellegrino, A.
    Todi, F.
    Zoffoli, M. V.
    Coiro, G.
    Marchetti, L.
    Di Palma, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [47] FOLFOX and nab-paclitaxel (nab-P) for advanced pancreatic cancer: A phase I study
    Safran, Howard
    Charpentier, Kevin
    Perez, Kimberly
    Mantripragada, Kalyan
    Austin, Trevor Clark
    Nadeem, Omar
    Lombardo, Alise
    Houlihan, Lindsay
    Fontes-Borts, Lucia
    Kolberg, Irene
    Mitchell, Kristen
    Rosati, Kayla
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [48] Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile
    Gonzalez-Martin, Antonio
    Alba, Emilio
    Ciruelos, Eva
    Cortes, Javier
    Llombart, Antonio
    Lluch, Ana
    Andres, Raquel
    Alvarez, Isabel
    Manuel Aramenda, Jose
    Ayala de la Pena, Francisco
    Barnadas, Agusti
    Batista, Norberto
    Calvo, Lourdes
    Galve, Elena
    Garcia-Palomo, Andres
    Angel Garcia-Saenz, Jose
    de la Haba, Juan
    Lopez, Rafael
    Lopez-Vivanco, Guillermo
    Martinez-Janez, Noelia
    Martinez de Duenas, Eduardo
    Plazaola, Arrate
    Rodriguez-Lescure, Alvaro
    Ruiz, Manuel
    Sanchez-Rovira, Pedro
    Santaballa, Ana
    Angel Segui, Miguel
    Tusquets, Ignasi
    Zamora, Pilar
    Martin, Miguel
    CURRENT CANCER DRUG TARGETS, 2016, 16 (05) : 415 - 428
  • [49] Bilateral macular edema secondary to nab-paclitaxel therapy for breast cancer
    Zhou, Zi-Yi
    Ye, Ya-Ting
    Zhu, Jing-Ting
    Sun, Dong-Jie
    Wang, Yu-Sheng
    Dou, Guo-Rui
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2024, 17 (10) : 1963 - 1966
  • [50] Carboplatin, nab-paclitaxel and bevacizumab as first-line treatment for metastatic breast cancer.
    Lo, S. S.
    Guo, R.
    Czaplicki, K. L.
    Robinson, P. A.
    Gaynor, E.
    Barhamand, F. B.
    Schulz, W. C.
    Kash, J. J.
    Horvath, L. E.
    Bayer, R. A.
    Petrowsky, C.
    De la Torre, R.
    Park, J. H.
    Albain, K. S.
    CANCER RESEARCH, 2012, 72
12345